Literature DB >> 17187203

Prophylactic treatment of migraine with topamax: long-term results.

Yu E Azimova1, G R Tabeeva.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17187203     DOI： 10.1007/s11055-007-0159-4

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN： 0097-0549


× No keyword cloud information.
  7 in total

Review 1.  Migraine pathophysiology.

Authors:  Peter J Goadsby
Journal:  Headache       Date:  2005-04       Impact factor: 5.887

Review 2.  General principles of migraine management: the changing role of prevention.

Authors:  Elizabeth Loder; David Biondi
Journal:  Headache       Date:  2005-04       Impact factor: 5.887

Review 3.  Molecular pharmacology of topiramate: managing seizures and preventing migraine.

Authors:  H Steve White
Journal:  Headache       Date:  2005-04       Impact factor: 5.887

Review 4.  Brain hyperexcitability: the basis for antiepileptic drugs in migraine prevention.

Authors:  K Michael Welch
Journal:  Headache       Date:  2005-04       Impact factor: 5.887

5.  Topiramate in migraine prevention: results of a large controlled trial.

Authors:  Stephen D Silberstein; Walter Neto; Jennifer Schmitt; David Jacobs
Journal:  Arch Neurol       Date:  2004-04

6.  Migraine as a risk factor for subclinical brain lesions.

Authors:  Mark C Kruit; Mark A van Buchem; Paul A M Hofman; Jacobus T N Bakkers; Gisela M Terwindt; Michel D Ferrari; Lenore J Launer
Journal:  JAMA       Date:  2004-01-28       Impact factor: 56.272

7.  Topiramate for migraine prevention: a randomized controlled trial.

Authors:  Jan Lewis Brandes; Joel R Saper; Merle Diamond; James R Couch; Donald W Lewis; Jennifer Schmitt; Walter Neto; Stefan Schwabe; David Jacobs
Journal:  JAMA       Date:  2004-02-25       Impact factor: 56.272
  7 in total
  1 in total

Review 1.  New drugs for migraine.

Authors:  Lars Jacob Stovner; Erling Tronvik; Knut Hagen
Journal:  J Headache Pain       Date:  2009-10-01       Impact factor: 7.277
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.